Medical panel adjusts Insurer scores in eight high incidence conditions
With the help of a panel of medical professionals, Finance & Technology Research Centre's (FTRC) reviews critical illness wordings within its product comparison tool Quality Analyser every six months. As a result of the review, insurer scores have been adjusted in eight high incidence conditions. These include: Benign brain tumour, carcinoma in situ of the colon or rectum, carcinoma in situ of the cervix, low grade prostate cancer, cardiomyopathy, coronary angioplasty, Parkinson's disease and...
Ex-Omnilife sales manager
'Personalisation without sacrificing privacy'
Free trial for advisers